Next Article in Journal
99mTc-Labeled FAPI SPECT Imaging in Idiopathic Pulmonary Fibrosis: Preliminary Results
Previous Article in Journal
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 16
Issue 10
10.3390/ph16101432
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Medicinal Plants Used for Eye Conditions in Mexico—A Review

by
Anuar Salazar-Gómez
1,
Amabile A. Velo-Silvestre
2,
Angel Josabad Alonso-Castro
3,* and
Luis Fernando Hernández-Zimbrón
1,2,*
1
Laboratorio de Investigación Interdisciplinaria, Área de Optomtería, Escuela Nacional de Estudios Superiores Unidad León, Universidad Nacional Autónoma de México (ENES-León UNAM), Blvd. UNAM 2011, Guanajuato 37684, Mexico
2
Clínica de Optometría, Escuela Nacional de Estudios Superiores Unidad León, Universidad Nacional Autónoma de México (ENES-León UNAM), Blvd. UNAM 2011, Guanajuato 37684, Mexico
3
Departamento de Farmacia, Universidad de Guanajuato, Noria Alta, Colonia Noria Alta Guanajuato, Guanajuato 36250, Mexico
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2023, 16(10), 1432; https://doi.org/10.3390/ph16101432
Submission received: 22 August 2023 / Revised: 2 October 2023 / Accepted: 5 October 2023 / Published: 9 October 2023
(This article belongs to the Section Natural Products)
Browse Figures
Versions Notes

Abstract

:
Medicinal plants have been historically significant for treating common human diseases in Mexico. Although some ethnobotanical research exists, limited ethnomedicinal data has documented medicinal plants employed for eye health. This review focuses on ethnomedicinal information and preclinical and clinical studies regarding medicinal plants used in Mexico for treating symptoms associated with eye conditions. An electronic database search was conducted by consulting scientific articles, books about Mexican herbal medicine, and academic theses. This work recorded 69 plant species belonging to 26 plant families, especially plants from the Crassulaceae family, which are used as remedies for irritation and infections in the eye. Eight of these medicinal plants have been the subject of preclinical studies using ocular models, and one medicinal plant has been tested in clinical trials. The evidence of pharmacological effects indicates the promising therapeutic potential of these medicinal plants for developing new treatments for eye conditions. However, toxicological studies are necessary to ensure safe application to the eye, particularly as traditional medicine continues to be relied upon worldwide. In addition, this review highlights the need to perform ethnobotanical and phytochemical studies in Mexico regarding the medicinal flora used as remedies for eye conditions.

1. Introduction

Eye health plays a critical role in the overall quality of life in the general population. The components of the visual system, along with its multiple functions, are frequently impacted by various health conditions, leading to the development of eye diseases. These conditions range from minor issues that typically do not cause vision impairment (e.g., dry eye, conjunctivitis, pterygium, blepharitis) to more severe ailments that can result in vision impairment or blindness, such as cataracts, glaucoma, corneal opacity, and refractive error [1]. In 2020, cataracts and glaucoma affected over 15 and 3 million adults aged older than 50 years, respectively, and were reported as the leading causes of blindness worldwide [2]. Although global approximations on the prevalence of eye conditions are scarce, the World Health Organization has estimated that the burden is disproportionately higher in low- and middle-income countries and among medically underserved populations [1]. In these countries, the initial approach to maintaining good eye health often involves self-treatment of eye conditions using traditional medicine [3,4,5]. The utilization of medicinal plants for preparing and administering ophthalmic remedies constitutes the foundation of traditional medicine in diverse cultures worldwide [6,7,8].
Herbal medicine plays a vital role in Mexico’s healthcare system. Throughout Mexican history, medicinal plants have been highly valued for their therapeutic properties in treating eye diseases [9]. The pre-Hispanic codices offer valuable insights into the botanical knowledge of the Nahuas, revealing the use of specific medicinal plants for treating eye conditions. For instance, pterygium was empirically treated with an eye drop made from the juice of Pinaropappus roseus (Less.) Less. is known as “chichicaquilitl” in Nahuatl, and “nubes de la córnea” (presumably corneal opacity) was treated with the juice of “tlatlayotli” [9]. The juice of the stem of a reed called “tule” or “ixtollin” was used to cure certain eye ailments. During the colonial period in Mexico, some of the earliest healthcare practices for eye conditions, including the use of medicinal herbs, were documented [10]. Alonso López de Hinojosos, a distinguished surgeon of New Spain in the second half of the 16th century, contributed significantly to the documentation of herbal medicine to treat several diseases. His work, “Summa y recopilación de cirugía con un arte para sangrar muy útil y provechosa” (Summa and compilation of surgery with art to bleed very useful and profitable), published in 1578, mentions more than 50 medicinal plants used as remedies for various diseases, including “tacamahaca” or “tequemahaca”, which is known to cure chronic eye diseases [11]. In later years, systematic documentation of botanical knowledge in Mexico gained momentum with the ethnobotanical movement in the 1960s and early 1970s, leading to field studies that provided valuable insights [12].
Traditional medicine continues to be prevalent in many rural areas, and researchers possess well-documented ethnobotanical data on medicinal plants used to treat common human diseases in various regions of Mexico [13,14]. However, efforts to document specific traditional knowledge of eye conditions are scarce. Only two studies on ethnobotanical information regarding eye care have been conducted worldwide, in Navarra, Spain [7] and Noakhali District, Bangladesh [15]. Therefore, this review aims to identify and organize the ethnomedicinal information available in the literature regarding medicinal plants used in Mexico for managing and treating eye conditions.

2. Results

2.1. Ethnobotanical Information of Medicinal Plants Used for Eye Conditions in Mexico

Since 1984, thirty-five ethnobotanical studies have been published and have mentioned at least one plant species for treating eye conditions. Most of the ethnobotanical studies were conducted in the states of Puebla and Oaxaca (Southern Mexico).
A total of 69 medicinal plants, belonging to 26 plant families, were identified as remedies for eye conditions or symptoms associated with eye problems (Table 1). Crassulaceae was the most represented family, with nine species (~12.8%), followed by Euphorbiaceae (seven species; 10%), Asteraceae (six species; 10%), and Lamiaceae (six species; ~8%). The most cited plants were Matricaria chamomilla L. (n = 10), Rosa × centifolia L. (n = 4), Euphorbia prostrata Aiton (n = 3), and Jatropha dioica Sessé (n = 3).
Medicinal plants used for treating eye conditions in Mexico involve various plant parts and preparation methods, depending on the specific eye disease or symptoms associated with eye problems. The leaves, flowers, and sap are the most used plant parts, usually applied topically as eye washes or eye drops prepared by infusion (15%), sap (8%), or by squeezing the leaves (7%) (Table 1).
The sap obtained from succulent plants, belonging to the Crassulaceae and Euphorbiaceae families, is known to store water as an adaptation to arid conditions [56,57,58]. Species belonging to the Euphorbiaceae family also produce latex used for treating eye diseases due to its antimicrobial, anti-inflammatory, and wound-healing effects [59,60]. Topical eye drops are favored for treating various ocular conditions due to their accessibility and non-invasive nature [61]. People often associate eye drops with natural plant fluids, such as squeezed sap or exudates, making them a common choice for managing anterior eye segment issues.
The medicinal plants cited in this review are used for treating eight specific eye conditions and seven symptoms associated with eye problems. However, many ethnobotanical reports lack detailed pathological information, only referring broadly to “eye problems”, “ophthalmological problems”, or “eye diseases” (Table 1).
Many medicinal plants are used for treating eye irritation and eye infections, which can be explained since the general population quickly perceives the symptoms of these diseases, such as red, burning, stinging, and watering eyes. In certain regions of Mexico, like San Miguel Tulancingo in Oaxaca (Southern Mexico), medicinal plants are applied for treating various eye conditions similar to those cited above [31].
Eye conditions have been documented using common Spanish names or traditional medical terms, such as “Vista venteada” (blurred sight), “Carnosidad”, and “nubes”. “Carnosidad” refers to the growth of conjunctival tissue over the cornea, whereas “nubes” describes corneal opacity. Both conditions are related to ocular surface disorders, which could include pterygium or corneal leucoma, respectively. Interestingly, the term “nubes” is also used to refer to cataracts, an intraocular disease that causes blurred vision. It is important to note that there are distinctions among these terms, and they have historical roots in ancient Mexican medical literature [62]. These oral traditions and expressions are still used, which reflects their enduring significance in local communities.
Medicinal plants used for treating conjunctivitis are administered by topical application, although some are also ingested for their potential systemic effects [63]. Conjunctivitis, a condition caused by infectious, allergic, toxic, or mechanical agents, is characterized by bulbar and tarsal conjunctiva inflammation in one or both eyes [64]. In this review, some eye ailments or symptoms related to eye problems might be associated with conjunctivitis, and their treatment involves the topical application of medicinal plants. Nerveless, T. officinale, M. chamomilla, P. polypodioides, L. angustifolia, and C. aurantiifolia are orally administered to treat conjunctivitis, whereas C. nobile and P. laevigata are used for eye infections. It is important to note that conventional therapy for conjunctivitis also involves the use of oral antivirals, antibiotics, and/or antihistaminic drugs, which are effective in many cases [2]. Therefore, the medicinal plants orally ingested by people could represent a promising source of new drugs to improve ocular therapy for infectious diseases—for example, the antibacterial effects of the root and aerial parts of T. officinale against several bacterial strains like Staphylococcus aureus and Pseudomonas aeruginosa [65]. In silico studies have revealed that luteolin and taraxacin, two components of T. officinale, are potential inhibitors against the methicillin-resistant gene mecI, a virulent factor in methicillin-resistant S. aureus [66]. Another example is M. chamomilla, one of the most common plants used for medicinal purposes. Solvent extracts of this plant and essential oils have demonstrated antimicrobial activity against several pathogens, including, S. aureus, P. aeruginosa, and Staphylococcus epidermidis. The antibacterial activity of M. chamomilla has been attributed to the presence of apigenin and α-linolenic acid [67]. L. angustifolia is a popular herb used to treat multiple diseases worldwide; in Mexico, oral infusions are used to treat conjunctivitis. Although an antimicrobial effect of the aqueous extract of L. angustifolia was not detected after the simulated gastrointestinal digestion in vitro [68], the essential oil of this plant has compounds such as linalool, linalyl acetate, β-ocimene, terpinen-4-ol, eucalyptol (1,8-cineole), camphor, β-caryophyllene, geraniol, and linalyl anthranilate that destroy the cellular membranes of pathogens and damage intracellular molecules [69]. Another example is C. aurantiifolia; Sandoval-Montemayor et al. [70] reported that isopimpinellin, bergamottin, palmitic acid, linoleic acid, oleic acid, 4-hexen-3-one, and citral from the hexane extract of fruit peel of this plant exert antibacterial activity against Mycobacterium tuberculosis (Figure 1). The bioactive compounds present in these plants may offer potential benefits for the treatment of eye conditions, and further research is needed to investigate their efficacy and safety.
Among the eye conditions reported in ethnobotanical surveys, the topical application of P. sagittifolium leaves to children’s eyelids during sleep for treating strabismus is particularly noteworthy, especially considering that conventional pharmacological treatment often involves the intramuscular injection of botulinum toxin as an alternative to surgical intervention [71]. Similarly, R. communis is used to treat strabismus in China and India [72,73]. Ricin, a toxin isolated from R. communis seeds, possesses ribosome-inactivating properties, making it a potential candidate for an in vivo locoregional remedy of strabismus and oculofacial dystonias. Furthermore, in vitro studies have suggested that ricin might serve as a substitute for the intramuscular injection of botulinum toxin in ocular dystonia therapy [74]. Because of its potential visual health benefits, R. communis has become the subject of several clinical trials. Therefore, it could be interesting to perform preclinical studies to corroborate the effectiveness of P. sagittifolium.
Of the 69 identified plants, 7 with ethnomedicinal information for eye conditions treatment are endemic to Mexico. Most of the species belong to the Sedum genus: S. allantoides, S. dendroideum, S. diffusum, S. morganianum, and S. oxypetalum. The Sedum genus, one of the most widely distributed genera within the Crassulaceae family, includes approximately 428 species [75,76], and 119 of these species are native to Mexico [77]. Many taxa of the Sedum genus are attractive to plant collectors due to their ornamental value, and are applied on extensive green roofs [78]. Members of the Sedum genus have also been reported for the empirical treatment of several diseases, such as skin inflammation, stomach pain, ulcers, hemorrhoids, and constipation [79,80,81,82]. Some of the Sedum species listed in Table 1 have been frequently used in Mexico for the treatment of gum diseases (S. dendroideum) [83], burns, skin infections, and mouth infections (S. oxypetalum) [84]. The dichloromethane extract of S. dendroideum promoted corneal healing in a murine model of pterygium-like eye lesions and exhibited immunomodulatory effects by reducing the levels of pro-inflammatory cytokines TNF-α and IL-1α, maintaining the expression of the anti-inflammatory cytokine IL-10. Moreover, the lyophilized sap of S. dendroideum showed antiproliferative activity in human pterygium fibroblasts and decreased the expression of vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF), two of the most important proteins implicated in angiogenesis [85,86]. The main components of the lyophilized sap of S. dendroideum are kaempferol glycosides, such as kaempferol-3-O-glucoside, kaempferol-3-O-rhamnoside, kaempferol-3-O-neohesperidoside-7-O-α-rhamnopyranoside, and kaempferol-3-O-glucoside-7-O-rhamnoside (Figure 2). It has been demonstrated that kaempferol inhibits angiogenesis by decreasing VEGF expression in human ovarian cancer cells [87], and decreases the expression of VEGF mRNA in H2O2-treated ARPE-19 cells and the VEGF in sodium iodate-induced retinal degeneration in rats [88]. The main components found in the dichloromethane extract of S. dendroideum are 1-triacontanol, β-sitosterol, α-tocopherol, α-amiryn, methyl octacosanoate, phytol, gedunin, hexacosanol, and 1-dotriacontanol [85] (Figure 2). Torrescano-De Labra et al. [85] suggested that gedunin is associated with the inhibition of the expression of proangiogenic growth factors and cytokines and the induction of angiogenesis inhibitors such as IL-10, whereas triacontanol and α-amyrin are involved in the autoinflammatory effect. These studies suggest that S. dendroideum holds potential as a therapeutic agent for managing pterygium and other ocular conditions.
It is worth noting that Mexico stands out due to having a significant number of Sedum species that have been traditionally used for treating eye conditions. The prominence of Sedum species is not only due to their frequency of being reported for eye treatments, but also because they are readily available as ornamental plants. Their widespread availability makes them a feasible and accessible resource for traditional medicine practices.

2.2. Pharmacological Efficacy and Safety Studies

Eight of the seventy plant species used for eye conditions in traditional Mexican medicine have been examined in preclinical studies using ocular models, and one plant species has been tested in clinical trials (Table 2). Most plant extracts are prepared using water or methanol, and only A. vera follows the information reported by Mexican ethnomedical claims for treating eye conditions. Species belonging to the Crassulaceae and Euphorbiaceae families lack pharmacological studies using crude sap or exudate directly squeezed from the leaves.
Most of the cited preclinical models were naphthalene- and selenite-induced cataracts, followed by water-loading and steroid-induced elevated intraocular pressure (IOP) and alkali-burned corneas. This can be explained, since cataracts and glaucoma are two leading causes of blindness [2]. Natural products have demonstrated promising therapeutic effects against cataracts and glaucoma [104,105]. Therefore, efforts to investigate new therapeutic strategies are needed.
The underlying principle of the naphthalene-induced in vivo cataract model is based on the toxicity in the lens produced by 1,2-naphthalenediol, a reactive metabolite derived from the biotransformation of naphthalene by hepatic cytochrome P450 (CYP) [106], whereas selenite disrupts the antioxidant defense mechanism of the lens by reducing GSH levels and impairs calcium homeostasis, leading to nuclear cataract formation [107]. The plants possessing anticataract activity are E. hirta, O. basilicum, and C. aurantium. The anti-cataract activity for these plants involves decreasing the opacity index and/or preventing peroxidative damage or enhancing the glutathione GSH levels. O. basilicum displays several pharmacological properties, among them antioxidant, analgesic, anti-inflammatory, antimicrobial, anti-neoplastic, anticancer, anti-osteoporotic, anti-ulcer, neuroprotective, immunomodulatory, hypoglycemic and hypolipidemic, and different bioactive chemical compounds have been identified from this plant [108]. Anand et al. [101] designated n-hexadecanoic acid, eugenol, and estragole (Figure 3) as major antioxidant components in the methanolic extract of O. basilicum. Eugenol has been associated with anti-inflammatory, anti-viral, anti-cancer, and cardioprotective activities (Figure 4). Multiple mechanisms of action in the inflammatory process have been described in eugenol, for example, inhibition of cyclooxygenase activity [108]; reducing myeloperoxidase activity, TNF-α levels, NF-κB expression, and lipid peroxidation malondialdehyde (MDA); and increased GSH levels [109]. The MDA reduction and GSH increase were observed in selenite-induced cataractogenesis in rat lenses in the presence of methanolic extract of O. basilicum [101]. Thus, eugenol could be related to this effect, but more detailed experiments should be performed to confirm this hypothesis.
There are models for assessing the IOP-lowering effect of plants, including the water-loading model and the steroid-induced IOP. The water-loading model (acute IOP elevation) is used to mimic primary angle closure, whereas the administration of corticosteroids such as prednisolone can lead to the development of IOP resembling the primary open angle in humans (chronic IOP elevation) [110]. Due to their IOP-lowering effects, D. carota and O. basilicum are plant species with anti-glaucoma potential. In traditional Mexican medicine, fresh leaves of D. carota have historically been used for addressing “eye problems”, although without specifying eye conditions. Two studies have investigated the effects of the seeds and roots of this plant, demonstrating their potential in reducing intraocular pressure (IOP) and mitigating retinal damage in diabetic rats, respectively, as outlined in Table 2. However, there is a lack of research focusing on the leaves of this plant. Considering the results presented by Agarwal et al. [89] and El-Mansi et al. [90] on seeds and roots, it is imperative to initiate investigations into the potential effects of D. carota leaves. This research would serve to validate the traditional use of these leaves for eye health among the Mexican population. A similar situation arises with C. roseus, a well-known plant marked for its diverse medicinal benefits; it is rich in alkaloids with anticancer activity. The roots of this plant are employed in traditional medicine to treat conjunctivitis. However, there is limited evidence on the advantages of methanol leaf extract in preventing alkali burn-induced corneal neovascularization in rabbits. Comprehensive examinations, including chemical, pharmacological, and toxicological studies, are warranted for C. roseus, with special attention to its alkaloid content [111].
A. vera and R. communis have been assessed in clinical trials of ocular ailments. A. vera is well-known as a bioactive natural product. Preclinical studies on the effect of A. vera described in Table 2 have revealed its potential to improve eye health. This is a plant used worldwide for therapeutic, pharmaceutical, and commercial applications. A. vera is one of the most ancient and well-documented medicinal plants and has been considered a “healing plant” due to its variety of medicinal properties. A. vera is composed mainly of polysaccharides, proteins, minerals, and water [112]. Traditionally, the leaf gel of A. vera has been used to treat wounds and other skin problems; its wound-healing properties are attributed to acemannan and glucomannan (Figure 3), two polysaccharides produced in the leaf gel [112,113]. Although A. vera gel is used extensively for treating dermal wounds, few studies have assessed this effect on corneal injury, and the molecular mechanisms underlying this beneficial effect are associated with the re-epithelialization process (Figure 4). In alkali-burned corneas in in vivo models of normal rabbits and rats as well as diabetic rats, topical application of Aloe vera gel promotes corneal wound healing by enhanced corneal re-epithelialization. In this process, many growth factors secreted from fibroblasts, such as the keratinocyte growth factor-1 (KGF-1), play an important role in re-epithelialization. It has been demonstrated that acemannan stimulated KGF-1 synthesis from gingival fibroblasts [114]. Special attention should be given to acemannan and glucomannan in further studies to identify their roles in treating eye conditions. R. communis showed therapeutic potential in managing ocular surface disease in clinical trials. A recent review reported the ocular surface benefits of using castor oil, derived from the bean of R. communis, in six different clinical trials [99]. Castor oil has demonstrated effectiveness in meibomian gland dysfunction and improvement of the ocular symptoms and signs of blepharitis. Clinical trials reported greater stability and less evaporation of tears after the ophthalmic use of castor oil for approximately 30 days. Due to the hydrophilic and hydrophobic characteristics of castor oil, the mechanism of action is related to stabilizing the tear film, and ricinoleic acid is proposed to participate in this process (Figure 4). Therefore, castor oil is a potential treatment for evaporative dry eye [99].
Indeed, the potential adverse effects of the medicinal plants used in self-care or accidental contact with the eyes should not be overlooked. Many of these plants show promising pharmacological activities, but they may also have the potential to cause ocular injuries or discomfort [115,116]. For instance, A. mexicana and S. dendroideum have been reported to induce burning sensations in the eyes when used topically [28,38]. Such adverse reactions highlight the need for cautious and informed use of these plants for ocular conditions. Therefore, it is crucial to assess toxicological studies, particularly with members of the Euphorbia genus and other plant species known to contain milky sap or latex, which have been associated with keratouveitis from accidental ocular exposure [117,118]. The combination of pharmacological efficacy and safety assessment will be pivotal in determining which medicinal plants can be effectively and safely used as complementary or alternative therapies for ocular conditions. Collaborative efforts between traditional medicine practitioners, ethnobotanists, toxicologists, and the scientific community will be crucial to ensuring a holistic approach to evaluating the potential of medicinal plants for ocular health, and ultimately improving patient care.

3. Future Perspectives

Traditional medicine has a long history of utilizing medicinal plants for various health conditions, including eye ailments. It is crucial to integrate traditional knowledge with scientific evidence and clinical research. This collaborative approach can lead to the development of novel and effective treatments for ocular disorders, ultimately enhancing eye health and patient well-being.
Given the promising findings from ethnobotanical surveys and preclinical studies, it is reasonable to consider advancing research on Sedum species for potential preclinical studies and toxicological assessments. These investigations can provide valuable insights into the safety and efficacy of Sedum-based treatments for ocular diseases, further supporting their potential as alternative or complementary therapies for eye health. Indeed, future pharmacological studies focusing on eye ailments should pay particular attention to plants from the Crassulaceae and Euphorbiaceae families, including members of the Sedum genus, which are commonly known as succulents. These plants have shown promising pharmacological activity and have been traditionally used to treat eye conditions. Investigating their potential therapeutic effects and identifying active compounds could lead to the development of novel and effective treatments for various eye diseases. The isolation and elucidation of the structure of the bioactive compounds used for improving eye health remain to be performed. In addition, it is necessary to elucidate the molecular mechanisms and perform toxicological studies with plant extracts and their active compounds which are used for treating eye conditions. These studies are scarce and are needed to assess their pharmacological effects in clinical trials.
As traditional medicine continues to be an important part of healthcare in several communities in Mexico, it is equally crucial to conduct thorough toxicological studies using in silico and in vitro (i.e., HaCaT cells, two- and three-dimensional cell culture models, and other cell lines) approaches. The use of in vitro and in silico studies can help to reduce the reliance on animal testing, providing more accurate and relevant results. These studies are essential to ensuring the safety of applying medicinal plants to the eye and informing people about the potential risks or adverse effects. Taking into consideration the potential hazards and verifying the safety of traditional remedies through modern scientific methods is paramount to protecting the ocular health of those relying on these practices. In addition, stability tests should be performed on pharmaceutical formulations containing plant extracts and plant-derived compounds. These tests are necessary because half of the pharmacological studies were conducted with drops containing plant extracts. The chemical standardization of these pharmaceutical preparations is crucial for the herbal medicine industry’s ability to provide high-quality products. These preparations should also follow good manufacturing practices throughout their processing. This pharmacological, pharmaceutical, and toxicological information could provide more evidence regarding the potential of medicinal plants from Mexico to be used for treating eye conditions. The integration of medicinal plants into a medical system is highly desirable, especially in low-income areas and rural zones of many countries. The current government in Mexico is promoting the use of medicinal herbs in rural communities. Traditional practitioners are sharing their ancient knowledge of herbal medicine with scientific researchers. The integration of traditional knowledge and modern research methodologies can lead to a better understanding of the benefits and risks associated with using medicinal plants for eye ailments. Collaborative efforts between traditional healers, scientists, and healthcare professionals can facilitate the gathering of valuable data on the safety and efficacy of these remedies. By combining the strengths of traditional medicine with evidence-based research, we can promote the safe and effective use of medicinal plants in eye care. Additionally, this approach can pave the way for the discovery of new therapeutic options and enhance overall eye health in Mexico and other countries.
The evidence of pharmacological effects demonstrated in preclinical studies indicates the promising therapeutic potential of these medicinal plants. As such, further research and exploration of these natural resources could pave the way for the development of new and effective treatments for various eye diseases. It is crucial to recognize the value of traditional medicine and to integrate it into modern healthcare practices, especially in regions where it has been an essential part of the culture and medical heritage.

4. Limitations of the Study

In many cases, the plant part used, the method of administration, and more information could not be obtained from the literature which we consulted. The accurate interpretation of old academic books was one of the main challenges of this work. In addition, as mentioned in Section 2.2, only a small number of medicinal plants followed the method of preparation reported by Mexican traditional medicine for treating eye conditions. This indicates the need to perform ethnobotanical studies in Mexico regarding the medicinal flora used for treating eye conditions. More detailed and updated information on the diseases treated with each medicinal plant is needed to plan pharmacological studies.

5. Materials and Methods

The data for this study were obtained through an extensive bibliographic search of the published studies related to Mexican ethnobotanical information. The search was conducted using electronic databases, including PubMed, ScienceDirect, and Google Scholar, up until 31 July 2023, without a specific period or language restriction. The search included the following keywords: “medicinal plant”, “ethnomedicinal”, “ocular”, “eye”, “eye diseases”, “eye conditions”, “ophthalmologic problems”, “pterygium”, “cataract”, “conjunctivitis”. Ethnobotanical knowledge was collected from scientific articles, Mexican herbal medicine books, or academic theses, and additional information was identified from the references in the retrieved articles. All ethnobotanical reports were included, even if they did not provide complete data on the preparation, route of administration, plant part used, or specific eye condition. The literature review gathered preclinical and clinical data from medicinal plants with ethnomedicinal purposes for eye health. Only studies focusing on the single use of a medicinal plant were considered. The accepted botanical names of each plant species were validated and updated, if necessary, according to The World Flora Online (http://www.worldfloraonline.org, accessed on 25 September 2023) and Plants of the World Online (https://powo.science.kew.org/, accessed on 25 September 2023). The chemical structures were drawn using the ChemDraw Ultra 12.0 software.

6. Conclusions

The rich biodiversity in Latin America, particularly in countries like Mexico, has fostered a strong tradition of using traditional medicine as the primary approach for treating non-severe and acute diseases. Over the centuries, ancient botanical knowledge has provided a wealth of information on the medicinal properties of various plants. This work indicates that there are a limited (11%) number of medicinal plants used for eye conditions with pharmacological studies. This indicates the importance of performing pharmacological and toxicological studies with these plant species.
Eye conditions are often associated with some of the most prevalent diseases in Mexico, such as Type 2 diabetes mellitus. Despite the significance of these eye conditions, the available literature suggests that people’s knowledge about specific eye diseases is limited. Instead, they tend to refer to generic eye problem names when discussing the use of medicinal plants for eye care. Most of the ethnobotanical studies in Mexico on medicinal plants used for eye conditions were documented in the central and southern regions. This review highlights the need to document the traditional knowledge of herbs used for treating eye diseases, especially in the states of Northern Mexico, where this information is scarce. This documentation is essential, as it serves as a reservoir of potential novel treatments for eye diseases.
Due to ethnobotanical information and preclinical findings, members of the Sedum genus are a promising alternative for the obtention of new bioactive compounds for treating eye conditions. Phytochemical studies with medicinal herbs are required to obtain new bioactive compounds.
Collaborative efforts between traditional healers, scientists, and healthcare professionals can bridge the gap between traditional knowledge and modern evidence-based medicine, ultimately benefiting the population’s eye health. By combining the wisdom of ancient botanical knowledge with scientific research, we can unlock the full potential of medicinal plants and contribute to the development of more comprehensive and effective eye care treatments in Mexico.

Author Contributions

Conceptualization, A.S.-G.; investigation, A.S.-G., A.A.V.-S. and A.J.A.-C.; writing—original draft preparation, A.S.-G., A.A.V.-S., A.J.A.-C. and L.F.H.-Z.; writing—review and editing, A.S.-G., A.A.V.-S., A.J.A.-C. and L.F.H.-Z.; supervision, A.J.A.-C. and L.F.H.-Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

A.S.-G. is a recipient of a postdoctoral fellowship from “Estancias Posdoctorales por México” program with the support of Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO. World Report on Vision; WHO: Geneva, Switzerland, 2019. [Google Scholar]
  2. Steinmetz, J.D.; Bourne, R.R.A.; Briant, P.S.; Flaxman, S.R.; Taylor, H.R.B.; Jonas, J.B.; Abdoli, A.A.; Abrha, W.A.; Abualhasan, A.; Abu-Gharbieh, E.G. Causes of Blindness and Vision Impairment in 2020 and Trends over 30 Years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study. Lancet Glob. Health 2021, 9, e144–e160. [Google Scholar] [CrossRef]
  3. Eze, B.I.; Chuka-Okosa, C.M.; Uche, J.N. Traditional Eye Medicine Use by Newly Presenting Ophthalmic Patients to a Teaching Hospital in South-Eastern Nigeria: Socio-Demographic and Clinical Correlates. BMC Complement. Altern. Med. 2009, 9, 40. [Google Scholar] [CrossRef]
  4. Gupta, N.; Vashist, P.; Tandon, R.; Gupta, S.K.; Kalaivani, M.; Dwivedi, S.N. Use of Traditional Eye Medicine and Self-Medication in Rural India: A Population-Based Study. PLoS ONE 2017, 12, e0183461. [Google Scholar] [CrossRef]
  5. Eticha, B.L.; Alemu, H.W.; Assaye, A.K.; Tilahun, M.M. Attitude towards Traditional Eye Medicine and Associated Factors among Adult Ophthalmic Patients Attending University of Gondar Comprehensive Specialized Hospital-Tertiary Eye Care and Training Center, Northwest Ethiopia. Clin. Optom. 2021, 13, 323–332. [Google Scholar] [CrossRef]
  6. Sandhu, P.S.; Singh, B.; Gupta, V.; Bansal, P.; Kumar, D. Potential Herbs Used in Ocular Diseases. J. Pharm. Sci. Res. 2011, 3, 1127. [Google Scholar]
  7. Calvo, M.I.; Cavero, R.Y. Medicinal Plants Used for Ophthalmological Problems in Navarra (Spain). J. Ethnopharmacol. 2016, 190, 212–218. [Google Scholar] [CrossRef]
  8. Shayanfar, J.; Ghasemi, H.; Esmaili, S.S.; Alijaniha, F.; Davati, A. Useful Medicinal Plants for Vision Impairment in Traditional Iranian Medicine. Galen Med. J. 2019, 8, e1285. [Google Scholar] [CrossRef]
  9. Graue y Díaz González, E. La Oftalmología Entre Los Indígenas del Anáhuac en la Época Prehispánica. Rev. Cult. Nuestra Am. 2018, 25, 100. [Google Scholar]
  10. Peralta Rodríguez, J.R. Eye Diseases and Their Treatment in the Novohispanic Population of México City. 16 Th and 17 Th Centuries. Secuencia 2008, 70, 11–44. [Google Scholar]
  11. Cordero-Galindo, E. La Materia Médica Mexicana En La Obra de Alonso López de Hinojosos. Cir. Cir. 1996, 64, 54–57. [Google Scholar]
  12. Camou-Guerrero, A.; Casas, A.; Moreno-Calles, A.I.; Aguilera-Lara, J.; Garrido-Rojas, D.; Rangel-Landa, S.; Torres, I.; Pérez-Negrón, E.; Solís, L.; Blancas, J. Ethnobotany in Mexico: History, Development, and Perspectives. In Ethnobotany of Mexico: Interactions of People and Plants in Mesoamerica; Springer: New York, NY, USA, 2016; pp. 21–39. [Google Scholar]
  13. Estrada-Castillón, E.; Villarreal-Quintanilla, J.Á.; Encina-Domínguez, J.A.; Jurado-Ybarra, E.; Cuéllar-Rodríguez, L.G.; Garza-Zambrano, P.; Arévalo-Sierra, J.R.; Cantú-Ayala, C.M.; Himmelsbach, W.; Salinas-Rodríguez, M.M. Ethnobotanical Biocultural Diversity by Rural Communities in the Cuatrociénegas Valley, Coahuila; Mexico. J. Ethnobiol. Ethnomed. 2021, 17, 21. [Google Scholar] [CrossRef]
  14. Medrano-Guerrero, A.; Carranza, E.; Juárez-Vázquez, M.C.; Solano, E.; Ruiz-Padilla, A.J.; Ruiz-Noa, Y.; Deveze-Alvarez, M.A.; Brennan-Bourdon, L.M.; Alonso-Castro, A.J. Medicinal Plants Used in Rural Communities from the Municipality of Dolores Hidalgo, Guanajuato, Mexico. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2023, 22, 524–536. [Google Scholar]
  15. Azam, M.N.K.; Biswas, S.; Ahmed, M.N. A Cross-Sectional Study of Ethnopharmacology in the Noakhali District of Bangladesh and Exploring Potential Ocular Immunostimulatory Activity of the Medicinal Plants for the Treatment of Eye Infections. PharmacologyOnline 2015, 1, 77–89. [Google Scholar]
  16. Kashanipour, R.A.; McGee, R.J. Northern Lacandon Maya Medicinal Plant Use in the Communities of Lacanja Chan Sayab and Nahá Chiapas, Mexico. J. Ecol. Anthropol. 2004, 8, 47–66. [Google Scholar] [CrossRef]
  17. White-Olascoaga, L.; Juan-Pérez, J.I.; Chávez-Mejía, C.; Gutiérrez-Cedillo, J.G. Flora Medicinal En San Nicolás, Municipio de Malinalco, Estado de México. Polibotánica 2013, 35, 173–206. [Google Scholar]
  18. Hopkins, A. Use of Network Centrality Measures to Explain Individual Levels of Herbal Remedy Cultural Competence among the Yucatec Maya in Tabi, Mexico. Field methods 2011, 23, 307–328. [Google Scholar] [CrossRef]
  19. Lara, E.A.; Fernández, E.; del Valle, J.M.Z.; Lara, D.J.; Aguilarq, A.; Van Damme, P. Etnomedicina En Los Altos de Chiapas, México. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2019, 18, 42–57. [Google Scholar] [CrossRef]
  20. Magaña Alejandro, M.A.; Gama Campillo, L.M.; Mariaca Méndez, R. El Uso de Las Plantas Medicinales En Las Comunidades Maya-Chontales de Nacajuca, Tabasco, México. Polibotánica 2010, 29, 213–262. [Google Scholar]
  21. Alfaro, M.A.M. Medicinal Plants Used in a Totonac Community of the Sierra Norte de Puebla: Tuzamapan de Gale Ana, Puebla, Mexico. J. Ethnopharmacol. 1984, 11, 203–221. [Google Scholar] [CrossRef]
  22. Lara Reimers, E.A.; Lara Reimers, D.J.; Chaloupkova, P.; Zepeda del Valle, J.M.; Milella, L.; Russo, D. An Ethnobotanical Survey of Medicinal Plants Used in Papantla, Veracruz, Mexico. Plants 2019, 8, 246. [Google Scholar] [CrossRef]
  23. Camacho-Hernández, C.; Lagunez-Rivera, L.; Aguilar-Contreras, A.; Solano, R. Ethnobotany of Medicinal Flora in Two Communities of the Mixteca Alta in Oaxaca, Mexico. Bot. Sci. 2022, 100, 912–934. [Google Scholar] [CrossRef]
  24. Vargas-Vizuet, A.L.; Lobato-Tapia, C.A.; Tobar-Reyes, J.R.; Solano-De la Cruz, M.T.; Marínez, A.I.; Fernández, A.R. Medicinal Plants Used in the Region of Teziutlán, Puebla, Mexico. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2022, 21, 224–241. [Google Scholar] [CrossRef]
  25. Ortiz Palacios, L.; Cervantes Gutiérrez, V.; Chimal Hernandez, A. Plantas Medicinales de San Francisco Tlaltenco, Tláhuac, 1st ed.; Universidad Autónoma Metropolitana: Mexico City, Mexico, 2017; ISBN 978-607-28-1278-9. [Google Scholar]
  26. Canales, M.; Hernández, T.; Caballero, J.; De Vivar, A.R.; Avila, G.; Duran, A.; Lira, R. Informant Consensus Factor and Antibacterial Activity of the Medicinal Plants Used by the People of San Rafael Coxcatlán, Puebla, México. J. Ethnopharmacol. 2005, 97, 429–439. [Google Scholar] [CrossRef]
  27. Estrada-Castillón, E.; Villarreal-Quintanilla, J.Á.; Rodríguez-Salinas, M.M.; Encinas-Domínguez, J.A.; González-Rodríguez, H.; Figueroa, G.R.; Arévalo, J.R. Ethnobotanical Survey of Useful Species in Bustamante, Nuevo León, Mexico. Hum. Ecol. 2018, 46, 117–132. [Google Scholar] [CrossRef]
  28. del Carmen Juárez-Vázquez, M.; Carranza-Álvarez, C.; Alonso-Castro, A.J.; González-Alcaraz, V.F.; Bravo-Acevedo, E.; Chamarro-Tinajero, F.J.; Solano, E. Ethnobotany of Medicinal Plants Used in Xalpatlahuac, Guerrero, México. J. Ethnopharmacol. 2013, 148, 521–527. [Google Scholar] [CrossRef]
  29. Nicholson, M.S.; Arzeni, C.B. Las Plantas Medicinales de Los Mercados de Monterrey, Nuevo León, México. Econ. Bot. 1993, 47, 184–192. [Google Scholar] [CrossRef]
  30. Reimers, E.; Cusimamani, E.; Rodriguez, E.; Zepeda del Valle, J.; Polesny, Z.; Pawera, L. An Ethnobotanical Study of Medicinal Plants Used in Zacatecas State, Mexico. Acta Soc. Bot. Pol. 2018, 87, 1–15. [Google Scholar] [CrossRef]
  31. García-Hernández, K.Y.; Vibrans, H.; Rivas-Guevara, M.; Aguilar-Contreras, A. This Plant Treats That Illness? The Hot–Cold System and Therapeutic Procedures Mediate Medicinal Plant Use in San Miguel Tulancingo, Oaxaca, Mexico. J. Ethnopharmacol. 2015, 163, 12–30. [Google Scholar] [CrossRef]
  32. Aguilar, M.G.F.; Hernández, V.H.; Mull, J.G.C. Plantas Útiles en el Cerro del Cubilete, Silao, Guanajuato. Jóvenes Cienc. 2018, 4, 32–36. [Google Scholar]
  33. Alvarez-Quiroz, V.; Caso-Barrera, L.; Aliphat-Fernández, M.; Galmiche-Tejeda, Á. Plantas Medicinales Con Propiedades Frías y Calientes en la Cultura Zoque de Ayapa, Tabasco, México. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2017, 16, 428–454. [Google Scholar]
  34. Zamora-Martínez, M.C.; de Pascual Pola, C.N. Medicinal Plants Used in Some Rural Populations of Oaxaca, Puebla and Veracruz, Mexico. J. Ethnopharmacol. 1992, 35, 229–257. [Google Scholar] [CrossRef] [PubMed]
  35. Orantes-García, C.; Moreno-Moreno, R.A.; Caballero-Roque, A.; Farrera-Sarmiento, O. Plantas Utilizadas en la Medicina Tradicional de Comunidades Campesinas e Indígenas de la Selva Zoque, Chiapas, México. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2018, 17, 503–521. [Google Scholar]
  36. Estrada-Castillón, E.; Villarreal-Quintanilla, J.Á.; Cuéllar-Rodríguez, L.G.; March-Salas, M.; Encina-Domínguez, J.A.; Himmeslbach, W.; Salinas-Rodríguez, M.M.; Guerra, J.; Cotera-Correa, M.; Scott-Morales, L.M. Ethnobotany in Iturbide, Nuevo León: The Traditional Knowledge on Plants Used in the Semiarid Mountains of Northeastern Mexico. Sustainability 2022, 14, 12751. [Google Scholar] [CrossRef]
  37. Arias Toledo, A.A.; Valverde Valdés, M.T.; Reyes Santiago, J. Las Plantas de La Región de Zapotitlán Salinas, Puebla, 1st ed.; Instituto Nacional de Ecología: Mexico City, Mexico, 2000; Available online: http://centro.paot.org.mx/documentos/ine/plantas_zapo.pdf (accessed on 24 June 2023).
  38. Moreno Castillo, E.E. Herbolaria Empleada en Santa Cruz Acalpixca, Xochimilco. In Comparación Entre La Época Prehispánica Según El Códice Badiano y La Actualidad; Universidad Autónoma Metropolitana Unidad Xochimilco: Mexico City, Mexico, 2019. [Google Scholar]
  39. Arellano, B. Etnobotánica Medicinal de La Cultura Mephaa en La Ciénega, Municipio de Malinaltepec, Guerrero, México; Universidad Autónoma del Estado de Guerrero: Iguala, Mexico, 2017. [Google Scholar]
  40. Sánchez-González, A.; Granados-Sánchez, D.; Simón-Nabor, R. Uso Medicinal de Las Plantas por Los Otomíes del Municipio de Nicolás Flores, Hidalgo, México. Rev. Chapingo Ser. Hortic. 2008, 14, 271–279. [Google Scholar] [CrossRef]
  41. Jerezano Alberto, V.; Ríos Saúl, A.; Tepancal-Gomez, E.; Salas-Mendosa, E.; Villanueva, L. Some Traditional Medicinal Plants of North Region from Puebla, Mexico: Uses and Potential Pharmacological Activity of Rumex Spp. Nat. Prod. Chem. Res. 2016, 4, 2. [Google Scholar]
  42. Domínguez, X.A.; Alcorn, J.B. Screening of Medicinal Plants Used by Huastec Mayans of Northeastern Mexico. J. Ethnopharmacol. 1985, 13, 139–156. [Google Scholar] [CrossRef]
  43. Ankli, A.; Heinrich, M.; Bork, P.; Wolfram, L.; Bauerfeind, P.; Brun, R.; Schmid, C.; Weiss, C.; Bruggisser, R.; Gertsch, J. Yucatec Mayan Medicinal Plants: Evaluation Based on Indigenous Uses. J. Ethnopharmacol. 2002, 79, 43–52. [Google Scholar] [CrossRef] [PubMed]
  44. Leonti, M.; Vibrans, H.; Sticher, O.; Heinrich, M. Ethnopharmacology of the Popoluca, Mexico: An Evaluation. J. Pharm. Pharmacol. 2001, 53, 1653–1669. [Google Scholar] [CrossRef]
  45. García-Alvarado, J.S.; Verde-Star, M.J.; Heredia, N.L. Traditional Uses and Scientific Knowledge of Medicinal Plants from Mexico and Central America. J. Herbs. Spices Med. Plants 2001, 8, 37–89. [Google Scholar] [CrossRef]
  46. Escamilla Pérez, B.E.; Moreno Casasola, P.; Utrera Pérez, E.; Utrera Urea, E.; Tronco López, C.; Tronco López, B.; Tronco Morales, G. Plantas Medicinales de La Matamba y El Piñonal, Municipio de Jamapa, Veracruz, 1st ed.; Instituto de Ecología A. C. (INECOL): Veracruz, México, 2015; ISBN 978-607-7579-44-1. [Google Scholar]
  47. Instituto Municipal de Planeación. Paleta Vegetal Municipal de Valle de Santiago, Gto.; Instituto Municipal de Planeación: Guanajuato, México, 2020. [Google Scholar]
  48. Rosado-Vallado, M.; Brito-Loeza, W.; Mena-Rejon, G.J.; Quintero-Marmol, E.; Flores-Guido, J.S. Antimicrobial Activity of Fabaceae Species Used in Yucatan Traditional Medicine. Fitoterapia 2000, 71, 570–573. [Google Scholar] [CrossRef]
  49. Dimayuga, R.E.; Agundez, J. Traditional Medicine of Baja California Sur (Mexico) I. J. Ethnopharmacol. 1986, 17, 183–193. [Google Scholar] [CrossRef] [PubMed]
  50. Arroniz, J.V.; Rosado, D.E.P.; Córdoba, P.Z.; García, E.M.G.; Muñoz, C.A.V.; Hernández, J.L.S. Conocimiento y Uso de Plantas Medicinales en Calpan, Puebla, México: Percepción de Varios Sectores Sociales. Bol. Latinoam. Caribe Plantas Med. Aromáticas 2023, 22, 676–688. [Google Scholar] [CrossRef]
  51. Andrade-Cetto, A. Ethnobotanical Study of the Medicinal Plants from Tlanchinol, Hidalgo, México. J. Ethnopharmacol. 2009, 122, 163–171. [Google Scholar] [CrossRef]
  52. Barrera-Catalán, E.; Herrera-Castro, N.D.; Catalán-Heverástico, C.; Ávila-Sánchez, P. Plantas Medicinales del Municipio de Tixtla de Guerrero, México. Rev. Fitotec. Mex. 2015, 38, 109–111. [Google Scholar] [CrossRef]
  53. Coronado-Aceves, E.W.; Sánchez-Escalante, J.J.; López-Cervantes, J.; Robles-Zepeda, R.E.; Velázquez, C.; Sánchez-Machado, D.I.; Garibay-Escobar, A. Antimycobacterial Activity of Medicinal Plants Used by the Mayo People of Sonora, Mexico. J. Ethnopharmacol. 2016, 190, 106–115. [Google Scholar] [CrossRef] [PubMed]
  54. Frei, B.; Baltisberger, M.; Sticher, O.; Heinrich, M. Medical Ethnobotany of the Zapotecs of the Isthmus-Sierra (Oaxaca, Mexico): Documentation and Assessment of Indigenous Uses. J. Ethnopharmacol. 1998, 62, 149–165. [Google Scholar] [CrossRef]
  55. Nava, R.F.; Zamora, D.R.; González, E.C. Notas Sobre Plantas Medicinales Del Estado de Querétaro, México. Polibotánica 2001, 12, 1–39. [Google Scholar]
  56. Webster, G.L. Euphorbiaceae BT—Flowering Plants. Eudicots: Malpighiales; Kubitzki, K., Ed.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 51–216. ISBN 978-3-642-39417-1. [Google Scholar]
  57. Xu, Z.; Deng, M. Crassulaceae BT—Identification and Control of Common Weeds: Volume 2; Xu, Z., Deng, M., Eds.; Springer: Dordrecht, The Netherlands, 2017; pp. 475–486. ISBN 978-94-024-1157-7. [Google Scholar]
  58. Heyduk, K. The Genetic Control of Succulent Leaf Development. Curr. Opin. Plant Biol. 2021, 59, 101978. [Google Scholar] [CrossRef]
  59. Benjamaa, R.; Moujanni, A.; Kaushik, N.; Choi, E.H.; Essamadi, A.K.; Kaushik, N.K. Euphorbia Species Latex: A Comprehensive Review on Phytochemistry and Biological Activities. Front. Plant Sci. 2022, 13, 1008881. [Google Scholar] [CrossRef]
  60. Licá, I.C.L.; dos Santos Soares, A.M.; de Mesquita, L.S.S.; Malik, S. Biological Properties and Pharmacological Potential of Plant Exudates. Food Res. Int. 2018, 105, 1039–1053. [Google Scholar] [CrossRef]
  61. Jumelle, C.; Gholizadeh, S.; Annabi, N.; Dana, R. Advances and Limitations of Drug Delivery Systems Formulated as Eye Drops. J. Control. Release 2020, 321, 1–22. [Google Scholar] [CrossRef]
  62. Leffler, C.T.; Schwartz, S.G.; Wainsztein, R.D.; Pflugrath, A.; Peterson, E. Ophthalmology in North America: Early Stories (1491–1801). Ophthalmol. Eye Dis. 2017, 9, 1179172117721902. [Google Scholar] [CrossRef]
  63. Sharma, P.; Singh, G. A Review of Plant Species Used to Treat Conjunctivitis. Phyther. Res. 2002, 16, 1–22. [Google Scholar] [CrossRef]
  64. Esteva Espinosa, E. Conjuntivitis: Sintomatología, Tratamiento y Medidas Preventivas. Offarm Farm. y Soc. 2004, 23, 60–66. [Google Scholar]
  65. Sharifi-Rad, M.; Roberts, T.H.; Matthews, K.R.; Bezerra, C.F.; Morais-Braga, M.F.B.; Coutinho, H.D.M.; Sharopov, F.; Salehi, B.; Yousaf, Z.; Sharifi-Rad, M. Ethnobotany of the Genus Taraxacum—Phytochemicals and Antimicrobial Activity. Phyther. Res. 2018, 32, 2131–2145. [Google Scholar] [CrossRef] [PubMed]
  66. Skariyachan, S.; Jayaprakash, N.; Bharadwaj, N.; Narayanappa, R. Exploring Insights for Virulent Gene Inhibition of Multidrug Resistant Salmonella Typhi, Vibrio Cholerae, and Staphylococcus Areus by Potential Phytoligands via In Silico Screening. J. Biomol. Struct. Dyn. 2014, 32, 1379–1395. [Google Scholar] [CrossRef] [PubMed]
  67. Sharifi-Rad, M.; Nazaruk, J.; Polito, L.; Morais-Braga, M.F.B.; Rocha, J.E.; Coutinho, H.D.M.; Salehi, B.; Tabanelli, G.; Montanari, C.; del Mar Contreras, M. Matricaria Genus as a Source of Antimicrobial Agents: From Farm to Pharmacy and Food Applications. Microbiol. Res. 2018, 215, 76–88. [Google Scholar] [CrossRef] [PubMed]
  68. Kemal, M.E.; Bakchiche, B.; Kemal, M.; Cheraif, K.; Kara, Y.; Bardaweel, S.K.; Miguel, M.G.; Yildiz, O.; Ghareeb, M.A. Six Algerian Plants: Phenolic Profile, Antioxidant, Antimicrobial Activities Associated with Different Simulated Gastrointestinal Digestion Phases and Antiproliferative Properties. J. Herb. Med. 2023, 38, 100636. [Google Scholar] [CrossRef]
  69. Leong, W.-H.; Lai, K.-S.; Lim, S.-H.E. Combination Therapy Involving Lavandula Angustifolia and Its Derivatives in Exhibiting Antimicrobial Properties and Combatting Antimicrobial Resistance: Current Challenges and Future Prospects. Processes 2021, 9, 609. [Google Scholar] [CrossRef]
  70. Sandoval-Montemayor, N.E.; García, A.; Elizondo-Treviño, E.; Garza-González, E.; Alvarez, L.; del Rayo Camacho-Corona, M. Chemical Composition of Hexane Extract of Citrus Aurantifolia and Anti-Mycobacterium Tuberculosis Activity of Some of Its Constituents. Molecules 2012, 17, 11173–11184. [Google Scholar] [CrossRef]
  71. Escuder, A.G.; Hunter, D.G. The Role of Botulinum Toxin in the Treatment of Strabismus. In Proceedings of the Seminars in Ophthalmology; Taylor & Francis: Abingdon, UK, 2019; Volume 34, pp. 198–204. [Google Scholar]
  72. Matos, F.J.A.; Machado, M.I.L.; Alencar, J.W.; Matos, M.E.O.; Craveiro, A.A. Plants Used in Traditional Medicine of China and Brazil. Mem. Inst. Oswaldo Cruz 1991, 86, 13–16. [Google Scholar] [CrossRef] [PubMed]
  73. Poddar, S.; Sarkar, T.; Choudhury, S.; Chatterjee, S.; Ghosh, P. Indian Traditional Medicinal Plants: A Concise Review. Int. J. Bot. Stud. 2020, 5, 174–190. [Google Scholar]
  74. Bortolotti, M.; Zanello, A.; Serra, L.; Biscotti, F.; Polito, L.; Bolognesi, A. Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy. Stresses 2023, 3, 270–281. [Google Scholar] [CrossRef]
  75. Eid, O.; Gonaid, M. Crassulaceae (Chemistry and Pharmacology)—A Review. Futur. J. Pharm. Sci. 2018, 4, 234–240. [Google Scholar] [CrossRef]
  76. Aragón-Parada, J.; Carrillo-Reyes, P.; Rodríguez, A.; Munguía-Lino, G. Diversidad y Distribución Geográfica del Género Sedum (Crassulaceae) en La Sierra Madre del Sur, México. Rev. Mex. Biodivers. 2019, 90, 1–17. [Google Scholar] [CrossRef]
  77. Villaseñor, J.L. Checklist of the Native Vascular Plants of Mexico. Rev. Mex. Biodivers. 2016, 87, 559–902. [Google Scholar] [CrossRef]
  78. Pérez, G.; Chocarro, C.; Juárez, A.; Coma, J. Evaluation of the Development of Five Sedum Species on Extensive Green Roofs in a Continental Mediterranean Climate. Urban For. Urban Green. 2020, 48, 126566. [Google Scholar] [CrossRef]
  79. Pieroni, A.; Giusti, M.E. Alpine Ethnobotany in Italy: Traditional Knowledge of Gastronomic and Medicinal Plants among the Occitans of the Upper Varaita Valley, Piedmont. J. Ethnobiol. Ethnomed. 2009, 5, 32. [Google Scholar] [CrossRef]
  80. Jarić, S.; Mačukanović-Jocić, M.; Djurdjević, L.; Mitrović, M.; Kostić, O.; Karadžić, B.; Pavlović, P. An Ethnobotanical Survey of Traditionally Used Plants on Suva Planina Mountain (South-Eastern Serbia). J. Ethnopharmacol. 2015, 175, 93–108. [Google Scholar] [CrossRef]
  81. Rigat, M.; Valles, J.; Gras, A.; Iglésias, J.; Garnatje, T. Plants with Topical Uses in the Ripollès District (Pyrenees, Catalonia, Iberian Peninsula): Ethnobotanical Survey and Pharmacological Validation in the Literature. J. Ethnopharmacol. 2015, 164, 162–179. [Google Scholar] [CrossRef]
  82. Mosaddegh, M.; Naghibi, F.; Moazzeni, H.; Pirani, A.; Esmaeili, S. Ethnobotanical Survey of Herbal Remedies Traditionally Used in Kohghiluyeh va Boyer Ahmad Province of Iran. J. Ethnopharmacol. 2012, 141, 80–95. [Google Scholar] [CrossRef] [PubMed]
  83. Rosas-Piñón, Y.; Mejía, A.; Díaz-Ruiz, G.; Aguilar, M.I.; Sánchez-Nieto, S.; Rivero-Cruz, J.F. Ethnobotanical Survey and Antibacterial Activity of Plants Used in the Altiplane Region of Mexico for the Treatment of Oral Cavity Infections. J. Ethnopharmacol. 2012, 141, 860–865. [Google Scholar] [CrossRef] [PubMed]
  84. Garcıa, V.M.N.; Gonzalez, A.; Fuentes, M.; Aviles, M.; Rios, M.Y.; Zepeda, G.; Rojas, M.G. Antifungal Activities of Nine Traditional Mexican Medicinal Plants. J. Ethnopharmacol. 2003, 87, 85–88. [Google Scholar] [CrossRef] [PubMed]
  85. Torrescano-De Labra, L.; Jiménez-Ferrer, E.; Camacho-Díaz, B.H.; Vargas-Villa, G.; González-Cortazar, M.; Herrera-Ruiz, M.; Ávila Reyes, S.V.; Solorza-Feria, J.; Jiménez-Aparicio, A.R. Corneal Healing and Recovery of Ocular Crystallinity with a Dichloromethane Extract of Sedum dendroideum DC in a Novel Murine Model of Ocular Pterygium. Molecules 2021, 26, 4502. [Google Scholar] [CrossRef] [PubMed]
  86. López-Montemayor, P.; Zavala, J.; Montalvo-Parra, M.D.; Guerrero-Ramírez, G.I.; Mayolo-Deloisa, K.; Enriquez-Ochoa, D.; Martínez-García, B.; Loya-García, D.; Guerrero-Martínez, A.M.; Valdez-García, J.E. Phytochemical Profile and Antioxidant and Antiproliferative Activity of Sedum dendroideum on Pterygium Fibroblasts. Evid.-Based Complement. Altern. Med. 2021, 2021, 5814221. [Google Scholar] [CrossRef] [PubMed]
  87. Luo, H.; Rankin, G.O.; Liu, L.; Daddysman, M.K.; Jiang, B.-H.; Chen, Y.C. Kaempferol Inhibits Angiogenesis and VEGF Expression through Both HIF Dependent and Independent Pathways in Human Ovarian Cancer Cells. Nutr. Cancer 2009, 61, 554–563. [Google Scholar] [CrossRef]
  88. Du, W.; An, Y.; He, X.; Zhang, D.; He, W. Protection of Kaempferol on Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage. Oxidative Med. Cell. Longev. 2018, 2018, 1610751. [Google Scholar] [CrossRef]
  89. Agarwal, R.; Gupta, S.K.; Srivastava, S.; Agrawal, S.S.; Saxena, R. Lowering of Intraocular Pressure by Topical Application of Daucus carota Seed Extract in Rabbits. Indian J. Exp. Biol. 2008, 46, 541–546. [Google Scholar]
  90. El-Mansi, A.A.; Al-Kahtani, M.A.; Rady, A.M.; El-Bealy, E.A.; Al-Asmari, A.M. Vitamin A and Daucus carota Root Extract Mitigate STZ-induced Diabetic Retinal Degeneration in Wistar Albino Rats by Modulating Neurotransmission and Downregulation of Apoptotic Pathways. J. Food Biochem. 2021, 45, e13688. [Google Scholar] [CrossRef]
  91. Ahmed, M.; Sahibzada, M.U.K.; Rasheed, H.M.; Khan, T.; Wahid, F.; Farooq, U.; Khusro, A.; Uddin, J.; Afzal, S.; Khan, A. Inhibition of Inflammation Associated Corneal Neovascularization by Dalbergia sissoo and Catharanthus roseus Leaf Extracts in an Animal Model. S. Afr. J. Bot. 2022, 151, 379–386. [Google Scholar] [CrossRef]
  92. Moghadam, M.R.; Jafarinasab, M.-R.; Yousefi, Z.; Moghaddam, A.S.; Memarzadeh, H.; Kanavi, M.R. Aloe vera Gel-Derived Eye Drops for Alkaline Corneal Injury in a Rabbit Model. J. Ophthalmic Vis. Res. 2020, 15, 7. [Google Scholar] [CrossRef] [PubMed]
  93. Atiba, A.; Wasfy, T.; Abdo, W.; Ghoneim, A.; Kamal, T.; Shukry, M. Aloe vera Gel Facilitates Re-Epithelialization of Corneal Alkali Burn in Normal and Diabetic Rats. Clin. Ophthalmol. 2015, 9, 2019–2026. [Google Scholar] [PubMed]
  94. Green, K.; Tsai, J.; Luxenberg, M.N. Effect of Aloe vera on Corneal Epithelial Wound Healing. J. Toxicol. Cutan. Ocul. Toxicol. 1996, 15, 301–304. [Google Scholar] [CrossRef]
  95. Vaghela, J.J.; Barvaliya, M.J.; Parmar, S.J.; Tripathi, C.R. Evaluation of Efficacy of Aloe vera (L.) Burm. f. Gel Solution in Methylcellulose-Induced Ocular Hypertension in New Zealand White Rabbits. J. Basic Clin. Physiol. Pharmacol. 2020, 32, 20190158. [Google Scholar] [CrossRef]
  96. Woźniak, A.; Paduch, R. Aloe vera Extract Activity on Human Corneal Cells. Pharm. Biol. 2012, 50, 147–154. [Google Scholar] [CrossRef]
  97. Ceravolo, I.; Mannino, F.; Irrera, N.; Squadrito, F.; Altavilla, D.; Ceravolo, G.; Pallio, G.; Minutoli, L. Health Potential of Aloe vera against Oxidative Stress Induced Corneal Damage: An “In Vitro” Study. Antioxidants 2021, 10, 318. [Google Scholar] [CrossRef] [PubMed]
  98. Rathnakumar, K.; Jaikumar, S.; Sengottuvelu, S. Effect of Euphorbia Hirta in Napthalene Induced Cataract in Rats. Res. J. Pharm. Technol. 2013, 6, 908–911. [Google Scholar]
  99. Sandford, E.C.; Muntz, A.; Craig, J.P. Therapeutic Potential of Castor Oil in Managing Blepharitis, Meibomian Gland Dysfunction and Dry Eye. Clin. Exp. Optom. 2021, 104, 315–322. [Google Scholar] [CrossRef]
  100. Agarwal, R.; Gupta, S.K.; Srivastava, S.; Saxena, R. IOP Lowering Effects of Ocimum basilicum Seed Extract in Two Rabbit Models of Ocular Hypertension. J. Clin. Health Sci. 2019, 4, 39–46. [Google Scholar] [CrossRef]
  101. Anand, T.; Sundararajan, M.; Anbukkarasi, M.; Thomas, P.A.; Geraldine, P. A Methanolic Extract of Ocimum basilicum Exhibits Antioxidant Effects and Prevents Selenite-Induced Cataract Formation in Cultured Lenses of Wistar Rats. Pharmacogn. J. 2019, 11, 496–504. [Google Scholar] [CrossRef]
  102. Anand, T.; Anbukkarasi, M.; Teresa, P.A.; Thomas, P.A.; Geraldine, P. Evaluation of the Putative Efficacy of a Methanolic Extract of Ocimum basilicum in Preventing Disruption of Structural Proteins in an in Vitro System of Selenite-Induced Cataractogenesis. Curr. Eye Res. 2020, 45, 696–704. [Google Scholar] [CrossRef] [PubMed]
  103. Umamaheswari, M.; Asokkumar, K.; Lalitha, V.; Sivashanmugam, T.; Subhadradevi, V. Anticataract and Antioxidant Activities of Citrus aurantium L. Peel Extract against Naphthalene Induced Cataractogenesis in Rats. J. Pharm. Res. 2011, 4, 680–682. [Google Scholar]
  104. Tewari, D.; Samoilă, O.; Gocan, D.; Mocan, A.; Moldovan, C.; Devkota, H.P.; Atanasov, A.G.; Zengin, G.; Echeverría, J.; Vodnar, D. Medicinal Plants and Natural Products Used in Cataract Management. Front. Pharmacol. 2019, 10, 466. [Google Scholar] [CrossRef] [PubMed]
  105. Sim, R.H.; Sirasanagandla, S.R.; Das, S.; Teoh, S.L. Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update. Nutrients 2022, 14, 534. [Google Scholar] [CrossRef] [PubMed]
  106. Stohs, S.J.; Ohia, S.; Bagchi, D. Naphthalene Toxicity and Antioxidant Nutrients. Toxicology 2002, 180, 97–105. [Google Scholar] [CrossRef]
  107. Muthaiah, R. Screening Methods for the Evaluation of Antiglaucoma and Anticataract Drugs. In Introduction to Basics of Pharmacology and Toxicology: Volume 3: Experimental Pharmacology: Research Methodology and Biostatistics; Springer: Berlin/Heidelberg, Germany, 2022; pp. 523–539. [Google Scholar]
  108. Dhama, K.; Sharun, K.; Gugjoo, M.B.; Tiwari, R.; Alagawany, M.; Iqbal Yatoo, M.; Thakur, P.; Iqbal, H.M.N.; Chaicumpa, W.; Michalak, I. A Comprehensive Review on Chemical Profile and Pharmacological Activities of Ocimum Basilicum. Food Rev. Int. 2023, 39, 119–147. [Google Scholar] [CrossRef]
  109. Barboza, J.N.; da Silva Maia Bezerra Filho, C.; Silva, R.O.; Medeiros, J.V.R.; de Sousa, D.P. An Overview on the Anti-Inflammatory Potential and Antioxidant Profile of Eugenol. Oxidative Med. Cell. Longev. 2018, 2018, 3957262. [Google Scholar] [CrossRef]
  110. Shah, M.; Cabrera-Ghayouri, S.; Christie, L.-A.; Held, K.S.; Viswanath, V. Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development. Pharm. Res. 2019, 36, 58. [Google Scholar] [CrossRef]
  111. Kumar, S.; Singh, B.; Singh, R. Catharanthus roseus (L.) G. Don: A Review of Its Ethnobotany, Phytochemistry, Ethnopharmacology and Toxicities. J. Ethnopharmacol. 2022, 284, 114647. [Google Scholar] [CrossRef]
  112. Bozzi, A.; Perrin, C.; Austin, S.; Vera, F.A. Quality and Authenticity of Commercial Aloe vera Gel Powders. Food Chem. 2007, 103, 22–30. [Google Scholar] [CrossRef]
  113. Massoud, D.; Alrashdi, B.M.; Fouda, M.; El-kott, A.; Soliman, S.A.; Abd-Elhafeez, H.H. Aloe vera and Wound Healing: A Brief Review. Braz. J. Pharm. Sci. 2023, 58, 1–11. [Google Scholar] [CrossRef]
  114. Jettanacheawchankit, S.; Sasithanasate, S.; Sangvanich, P.; Banlunara, W.; Thunyakitpisal, P. Acemannan Stimulates Gingival Fibroblast Proliferation; Expressions of Keratinocyte Growth Factor-1, Vascular Endothelial Growth Factor, and Type I Collagen; and Wound Healing. J. Pharmacol. Sci. 2009, 109, 525–531. [Google Scholar] [CrossRef] [PubMed]
  115. Fraunfelder, F.W. Ocular Side Effects from Herbal Medicines and Nutritional Supplements. Am. J. Ophthalmol. 2004, 138, 639–647. [Google Scholar] [CrossRef] [PubMed]
  116. Al Ghadeer, H.; Al Gethami, A.; Al Sulaiman, H.; Bukhari, T. Corneal Toxicity after Self-Application of Calotropis Procera (Ushaar) Latex: Case Report and Analysis of the Active Components. Middle East Afr. J. Ophthalmol. 2019, 26, 40. [Google Scholar] [CrossRef]
  117. Basak, S.K.; Bakshi, P.K.; Basu, S.; Basak, S. Keratouveitis Caused by Euphorbia Plant Sap. Indian J. Ophthalmol. 2009, 57, 311. [Google Scholar] [CrossRef]
  118. da Silva Conci, L.; Alves, D.L.S.; Agostini, F.S.; Frossard, J.C.; Alves, D.C.S.; Alves, D.H.S.; Pinheiro, A.G. Keratouveitis Caused by Euphorbia milii Sap: Case Report and Overview. Rev. Bras. Oftalmol. 2021, 80, 1–3. [Google Scholar]
Pharmaceuticals 16 01432 g001
Figure 1. Chemical structures of compounds with antibacterial activity.
Figure 1. Chemical structures of compounds with antibacterial activity.
Pharmaceuticals 16 01432 g001
Pharmaceuticals 16 01432 g002
Figure 2. Chemical structures of some compounds found in S. dendroideum.
Figure 2. Chemical structures of some compounds found in S. dendroideum.
Pharmaceuticals 16 01432 g002
Pharmaceuticals 16 01432 g003
Figure 3. Chemical structures of compounds found in O. basilicum (n-hexadecanoic acid, eugenol, and estragole), R. communis (ricinoleic acid) and A. vera (acemannan and glucomannan).
Figure 3. Chemical structures of compounds found in O. basilicum (n-hexadecanoic acid, eugenol, and estragole), R. communis (ricinoleic acid) and A. vera (acemannan and glucomannan).
Pharmaceuticals 16 01432 g003
Pharmaceuticals 16 01432 g004
Figure 4. The proposed therapeutic approaches of medicinal plants and their main components in eye conditions. Pharmacological studies point towards antioxidant, antiproliferative, and anti-inflammatory activities as well as corneal wound healing and improvement in tear film stability. VEGF: Vascular endothelial growth factor; CTGF: connective tissue growth factor; TNF-α: tumor necrosis factor (TNF)-alpha; IL-10: interleukin-10; MDA: malondialdehyde; GSH: glutathione (GSH); KGF-1: keratinocyte growth factor-1.
Figure 4. The proposed therapeutic approaches of medicinal plants and their main components in eye conditions. Pharmacological studies point towards antioxidant, antiproliferative, and anti-inflammatory activities as well as corneal wound healing and improvement in tear film stability. VEGF: Vascular endothelial growth factor; CTGF: connective tissue growth factor; TNF-α: tumor necrosis factor (TNF)-alpha; IL-10: interleukin-10; MDA: malondialdehyde; GSH: glutathione (GSH); KGF-1: keratinocyte growth factor-1.
Pharmaceuticals 16 01432 g004
Table 1. Ethnobotanical information on medicinal plants used for eye conditions in Mexico.
Table 1. Ethnobotanical information on medicinal plants used for eye conditions in Mexico.
Plant FamilyPlant NameCommon Name
(Spanish or Autochthonal)		Plant Part UsedMedicinal UseEthnobotanical Information/EstateReference
AnacardiaceaeMetopium brownei (Jacq.) Urb.Che’ chen (Lacandon); Chechem (spanish)Sap/crude “Bleed sap from the base of the tree”Eye irritation“Wash eyelids with sap”/Chiapas[16]
Schinus molle L.Pirú (Spanish)Not specifiedEye cleanerNot specified/Estado de México[17]
Spondias purpurea L.Ciruela (Spanish)Not specifiedEye painNot specified/Yucatán[18]
ApiaceaeDaucus carota L.Zanahoria (Spanish)Fresh leavesEye problemsSqueezed/Chiapas[19]
ApocynaceaeCatharanthus roseus (L.) G.DonVicaria (Spanish and Chontal)RootConjunctivitisNot specified/Tabasco[20]
AraceaePhilodendron sagittifolium Liebm.“chapiz grande”, “malaste grande” (Spanish); “tantai” (Totonaca)LeavesTo cure strabismus“Leaves applied to eyelids of sleeping children, to cure strabismus”/Puebla[21]
ArecaceaeAcrocomia aculeata (Jacq.) Lodd. ex Mart.Coyol redondo, palma (Spanish)Fresh barkEye problemsDecoction/Veracruz[22]
AsphodelaceaeAloe vera (L.) Burm. f.Sábila (Spanish)Leaf gelEye cleanerCrushed/Oaxaca[23]
AsteraceaeArnica montana L.Arnica (Spanish)Aerial partsImproves eyesightDecoction and topical administration/Puebla[24]
Chamaemelum nobile (L.) All.Manzanilla (Spanish)Whole plantEye infectionOral infusion of whole plant/Guanajuato[14]
Helianthus annuus L.Girasol (Spanish)Fresh leavesEye problemsInfusion/Chiapas[19]
M. chamomillaManzanilla (Spanish)Not specifiedEye cleanerDecoction, infusion, washes/Oaxaca[23]
Not specifiedEye irritationNot specified/Mexico city[25]
Aerial partsEye infection“Tea, the infected eyes are washed with it (topical)”/Puebla[26]
Leaves and inflorescencesEye infection“Applied as eye drops”/Nuevo León[27]
Leaves, whole plantConjunctivitisInfusion, oral/Guerrero[28]
Whole plantNot specifiedThe infusion is used as eye drops/Nuevo León[29]
Leaves and flowersEye problemsNot specified/Zacatecas[30]
Not specifiedEye irritationNot specified/Oaxaca[31]
Fresh leavesEyes problemBath/Veracruz[22]
Leaves and flowersEye cleaner“Put two warm drops of the 5apónica directly in the eye”/Coahuila[13]
Taraxacum officinale F.H. WiggDiente de león (Spanish)Aerial part, rootConjuntivitisDecoction, oral/Puebla[24]
Zinnia peruviana (L.) L.Mal de ojo (Spanish)Not specifiedEye irritationNot specified/Guanajuato[32]
CommelinaceaeCommelina erecta L.“matalín” (Spanish); “kasmalj” (Totonaca)SapEye cleaner“Sap used as eyedrops to clean the eyes”/Puebla[21]
Tradescantia spathacea Sw.Maguey morado (Spanish)LeavesEye irritationInfusion of leaves and applied as eye drops/Tabasco[33]
Tradescantia zebrina var. zebrinaMatlali color morado (Spanish); hierba de 1os ojos (Spanish)LeavesCataract“The juice from its leaves and twigs is put directly over the cataract of the eye”/Oaxaca, Puebla, and Veracruz[34]
CostaceaeCostus pulverulentus C. PreslCañita agría (Spanish)StemEye irritationInfusion of stem and applied as eye drops/Chiapas[35]
CrassulaceaeEcheveria elegans var. simulans Poelln.Siempre viva (Spanish)SapRed eyes, irritated eyesEye drops/Nuevo León[36]
Kalanchoe pinnata (Lam.) Pers.Siempre viva, “hoja fresca” (Spanish); “Tkuya tuwan” (Totonaca)LeavesEye cleaner“Sap of leaves used to clean the eyes”/Puebla[21]
Sedum allantoides RoseCola de Borrego (Spanish)SapConjuntivitisThe sap of this plant is used as an antiseptic in mild eye infections, conjunctivitis, and children with thrush (Candida albicans infection)/Puebla[37]
Sedum dendroideum Moc. & Sessé ex DC.Siempre viva (Spanish)Leaves/sapEye painDetached leaves are squeezed directly into the eye. A small amount of sap is directly applied to the eye to avoid a burning sensation/Mexico City[38]
Siempre viva (Spanish)Not specifiedEye infectionCrushed/Oaxaca[23]
Sedum diffusum S. WatsonChismes (Spanish)SapRed eyes, irritated eyesEye drops/Nuevo León[36]
Sedum morganianum E.WaltherCola de Borrego (Spanish)Fresh leavesEye infectionSqueeze/Chiapas[19]
Iná meda (Me 'phaa)Leaves“Carnosidad” 1 Eye infectionTopical/Guerrero[39]
Sedum oxypetalum KunthSiempre viva (Spanish)Leaves, stem“Carnosidad” 1, eye cleanerExtract drops and poultice (Cataplasm)/Mexico City[25]
Sedum praealtum A.DC.Siempre viva “damdo” (Spanish)LeavesEye irritationNot specified/Hidalgo[40]
Siempreviva; flor de siempreviva (Spanish); su sá (Ngiba)Not specifiedEye irritationNot specified/Oaxaca[31]
Sedum × rubrotinctum R.T.ClausenDedo de niño (Spanish)LeavesEye infection“Cut leaves and squeeze out the liquid until it contains and apply a few drops in the ear or eye if it is the case”/Puebla[41]
EuphorbiaceaeCroton cortesianus KunthNot specifiedSapEye infectionNot specified/southeast San Luis Potosi and northern Veracruz[42]
Croton reflexifolius KunthNot specifiedResinEye problems“The resin of Croton reflexifolius is used for treating pimples in the mouth (herpes) and eye problems”/Yucatán[43]
Croton repens Schltdl.Sangre de grado de la sabana/Soj kobak/Soj muk (Popoluca)SapRetina complication“The sap of astringent plants is applied to the eye for cleaning the retina”/Veracruz[44]
Euphorbia hirta L.Hierba de la golondrina (Spanish)StemEye irritationNot specified/Hidalgo[40]
Not specifiedConjuntivitisNot specified/Estado de México[17]
E. prostrataHierba de la golondrina (Spanish)Whole plantCataracts“An infusion of the whole plant is used for diarrhea and cataracts”/Nuevo León[29]
LeavesEye diseases“Two or three leaves of the plant are squeezed, and the fluid is applied to the eyes”/Not specified[45]
Golondrina (Spanish)LeavesWatering eyes, “nubes” 2Two or three leaves of the plant are squeezed into the eye/Veracruz[46]
J. dioicaSangre de drago, sangregado (Spanish)Aerial parts and rootsEye irritationInfusion, oral/Not specified[45]
Sangregado (Spanish)Not specifiedEye irritation, “nubes” 2, blindnessNot specified/Guanajuato[47]
Sangre de drago, sangre de grado (Spanish)SapEye cleaner“Apply a drop of sap to the eye”/Coahuila[13]
Ricinus communis L.Higuerilla (Spanish)Not specifiedConjunctivitisNot specified/Estado de México[17]
FabaceaeSenna spectabilis (DC.) H.S. Irwin & BarnebyFlor de todos 1os santos (Spanish)FlowersTo wash the eyes“The concoction of the flowers is used to wash the eyes and avoiding ‘evil eye’ (mal de ojo) occurs”/Oaxaca, Puebla and Veracruz[34]
Dalbergia glabra (Mill.) Standl.Not specifiedLeavesEye infections“Infusion used to treat eye infections”/Yucatán[48]
Gliricidia sepium (Jacq.) KunthCocohite (Spanish); aj chánté (Chontal)LeavesConjunctivitisNot specified/Tabasco[20]
Prosopis laevigata (Humb. & Bonpl. ex Willd.) M.C.Johnst.Mezquite (Spanish)LeavesEye problems“Tea from leaf shoots, the eyes are washed”/Puebla[26]
Mezquite (Spanish); Mizquitl (Nahuatl)LeavesEye infectionInfusion, oral/Guerrero[28]
Senna racemosa (Mill.) H.S.Irwin & BarnebyNot specifiedBarkEye infections“Infusion is used to treat eye infections”/Yucatán[48]
FouquieriaceaeFouquieria diguetii (Tiegh.) I.M.Johnst.Palo Adán (Spanish)Flower’s sapCataract“Applied directly to the eye”/Baja California Sur[49]
LamiaceaeAgastache mexicana (Kunth) Lint & Epling.Toronjil (Spanish)Not specifiedEye cleanerInfusion, washes/Oaxaca[23]
Lavandula angustifolia Mill.Lavanda (Spanish)LeavesConjunctivitisInfusion, oral/Puebla[50]
Ocimum basilicum L.Albahaca (Spanish)Not specifiedEye painNot specified/Yucatán[18]
Albahacar (Spanish); Albajaka (Chontal)Aerial partConjunctivitisNot specified/Tabasco[20]
Ocimum carnosum (Spreng.) Link & Otto ex BenthSiempreviva (Spanish)LeavesCataractMaceration, topical/Hidalgo[51]
Rosmarinus officinalis L.Romero (Spanish)Aerial partBlurry visionDecoction, infusion, crushed; oral/topical/Puebla[24]
Salvia hispanica L.Chía (Spanish)Seeds“Basura en el ojo” (foreign body sensation)Seeds are mashed and put into the eye. Tear production helps to eliminate the foreign body sensation/Guerrero[52]
LauraceaePersea americana Mill.Aguacate (Spanish); tchunue (Ngiba)Not specifiedEye irritationNot specified/Oaxaca[31]
MalvaceaeMalvaviscus arboreus Dill. ex Cav.Sibí; Sibil (Spanish); Yopo 'aj ts 'ibi (Chontal)Leaves“Carnosidad” 1Not specified/Tabasco[20]
Pachira aquatica Aubl.Zapote de agua (Spanish); Ajp 'o 'te c (Chontal)CortexConjuntivitisNot specified/Tabasco[20]
PapaveraceaeArgemone mexicana L.Tachina, Táchino (Mayo); Xazácös; (Seri); Cardo (Spanish); Chicalote (Spanish)ShootsEye infectionDecoction/Sonora[53]
Chicale (Spanish); Chicalotl (Nahuatl)Flower, latexEye infectionMaceration, topical/Guerrero[28]
Argemone ochroleuca SweetChicalote (Spanish)Not specifiedEye infection, cataractsInfusion, washes/Oaxaca[23]
Flowers, latex“Carnosidad” 1, eye irritationExtract drops/Mexico City[25]
Chicatl (náhuatl)Latex“Carnosidad” 1“1 or 2 drops of latex into the eye. To improve effectiveness, 1 drop is recommended before going to sleep/Guerrero[52]
Argemone platyceras Link & OttoChicalote blanco (Spanish)Flowers, latex“Carnosidad” 1,eye irritationExtract drops/Mexico city[25]
Chicalote (Spanish)Not specifiedEye painNot specified/Estado de México[17]
PlantaginaceaePlantago major L.Lantén (Spanish)Not specifiedEye cleanerWashes/Oaxaca[23]
PolypodiaceaePleopeltis polypodioides (L.) E.G. Andrews & WindhamSiempre viva (Spanish)Aerial partConjuntivitisInfusion, oral/Puebla[24]
RhamnaceaeSarcomphalus obtusifolius (Hook. ex Torr. & A.Gray) HauenschildJutuqui, Jo’otoro (Mayo); Bachata, Ciruela del monte, Hui-chillame (Spanish)ShootsEye infectionsDecoction/Sonora[53]
RosaceaeRosa sp.Rosa de castilla (Spanish)FlowersEye cleaner“Boiling two to three roses and wash the eyes with the infusion”/Veracruz[46]
Rosa × centifoliaNot specifiedPetal; flowerOphthalmological problemsNot specified/Oaxaca[54]
Rosa de Castilla (Spanish)Flowers “Tea (oral) and used to wash the eye (topical)”/Puebla[26]
Not specifiedEye irritationNot specified/Oaxaca[31]
Not specifiedEye irritationNot specified/Mexico city[25]
Rosa chinensis Jacq. Rosa concha (Spanish)FlowersTo reduce swelling“The concoction of the flower is put directly over the eyes to reduce swelling”/Oaxaca, Puebla, and Veracruz[34]
Rosa (Spanish)Not specifiedEye problemsNot specified/Estado de México[17]
Rosa gallica L.Rosa de castilla (Spanish)Not specifiedConjunctivitis; improves eyesight; eyes washInfusion, washes/Oaxaca[23]
Rosa de castilla (Spanish); Nich i castilla (Chontal)Flowers“Carnosidad” 1Not specified/Tabasco[20]
Rosa de castilla (Spanish)FlowersEye infectionInfusion, washes/Guanajuato[14]
Rosa moschata Herrm.Flor de concha, Rosa Concha (Spanish); U nich pat (Chontal)Flowers“Carnosidad” 1,eye irritationNot specified/Tabasco[20]
Rosa multiflora Thunb.Rosa blanca (Spanish)FlowersEye irritationInfusion, vaporization, topical/Puebla[24]
RutaceaeCitrus × aurantiifolia (Christm.) SwingleLimón (Spanish)Leaves; fruitConjunctivitisInfusion, essential oil/oral/Central and southern Mexico[45]
Citrus × aurantium L.Limonero (Spanish)Not specifiedEye cleanerInfusion, washes/Oaxaca[23]
Citrus × limon (L.) OsbeckLima chichi (Spanish)Fresh fruitInfection“Infection in the eye” Squeezed/Veracruz[22]
Ruta chalepensis L.Ruda (Spanish)Whole plant“Vista venteada”“The powdered plant is mixed with aguardiente, an alcoholic beverage, and camphor, the resultant paste is applied close to the eyes to treat blurred sight”/Querétaro[55]
SolanaceaeCapsicum baccatum L.Hoja de chile (Spanish)Aerial parts; fruit; leafOphthalmological problemsNot specified/Oaxaca[54]
ViburnaceaeSambucus mexicana C.Presl ex DC.Not specifiedFlower; leafOphthalmological problemsNot specified/Oaxaca[54]
VitaceaeCissus verticillata subsp. verticillataNot specifiedAerial parts; fruitOphthalmological problemsNot specified/Oaxaca[54]
Vitis tiliifolia Humb. & Bonpl. ex Schult.Bejuco de uva (Spanish)LeavesEye cleaner“Boiling the leaves with water, the infusion is used to wash the eyes”/Querétaro[55]
Uva silvestre (Spanish)Not specified“Carnosidad” 1Not specified/Estado de México[17]
ZingiberaceaeHellenia speciosa (J. Koenig) S.R. DuttaPäsak (Lacandon); Jengibre (Spanish)Sap/crude “Cut stalk and drain sap”Eye irritation“The sap is directly applied to eyes”/Chiapas[16]
1 Growth of conjunctival tissue over the cornea; 2 corneal opacities.
Table 2. Pharmacological studies (in vitro, in vivo, and clinical trials) of medicinal plants used for eye conditions in Mexico.
Table 2. Pharmacological studies (in vitro, in vivo, and clinical trials) of medicinal plants used for eye conditions in Mexico.
Species NameExtractVehicle or FormulationStudy/Model or Clinical
Intervention		Way of
Administration		OutcomeReference
D. carotaAqueous seed extractDried and powdered extract was dissolved in 0.25% hydroxy propyl methylcelluloseIn vivo/water-loading model and steroid induced model IOP in rabbitsTopically (instilled) 50 µLIOP reduction of 29.39% (water-loading model) and 30.27% (steroid-induced model) at 0.6%.[89]
Chloroform root extract-In vivo/STZ-induced diabetic retinal damage in ratsOrally administered at 200 mg/kg/day↑ Serum plasma retinol (~1.70%). Protection and attenuation of retinal damage via downregulation of apoptotic pathways, enhancing oxidative capacity, and modulation of retinal neurotransmission at 200 mg/kg/day.[90]
C. roseus70% methanol leaf extractEye drops (1% w/v) were prepared in normal saline and DMSO (4%)In vivo/alkali burn-induced corneal neovascularization in rabbitsTopically applied (instilled) three eye drops three times a day↓ Vessel length and thickness; their propagation towards the cornea was stopped.[91]
A. veraLeaf gelAloe vera gel-derived eye dropsIn vivo/alkali-burned corneas in rabbitsTopically (instilled) eye drops four times a day for seven days↓ Corneal epithelial defect area; ↓ rate of keratocyte loss.[92]
Eye drops, Gel lyophilized powder (60 mg/mL) in saline.In vivo/alkali-burned corneas in normal and diabetic ratsTopically applied (instilled) eye drops four times daily for 3 daysPromoting corneal wound healing through facilitating re-epithelization and reducing inflammation in diabetic rats.[93]
Eye drops, gelIn vivo/mechanically induced corneal epithelial lesion in rabbits.Topically applied (instilled) 50 µL eye drops applied three times dailyNo effect[94]
6 and 12% gel solutions with potassium sorbate as a preservativeIn vivo/methylcellulose-induced ocular hypertension in rabbitsTopically applied (instilled) eye drops applied every 8 h for 2 daysIOP reduction of 8.6 and 10.4% with 6 and 12% gel solutions, respectively[95]
Ethanol, ethyl acetate, and heptane extractsDissolved in DMSOIn vitro/human normal corneal cell line 10.014 pRSV-T (ATCC No. CRL-11515)-↓ NO production
↓ IL-1β, IL-6, TNF-α and IL-10 production		[96]
Methanol extract from fresh leavesLyophilized powder (100 μg/mL)In vitro/epithelial adenovirus 12-SV40 hybrid-transformed HCE cells (ATCC® CRL-11135™); exposure to H2O2-↑ Cell viability
↓ ROS production and MDA levels
↑ Gene expression of Nrf2, SOD2 and Catalase
↓ COX-2, TNF-α, IL-6 and IL-1β mRNA expression		[97]
S. dendroideumDichloromethane extract from leaf juice; lyophilized powder20 mg/mL dichloromethane extract dissolved in vehicle (cyclodextrin and Tween 20 solution)In vivo/tetradecanoylphorbol acetate-induced pterygium-like eye lesion in miceTopically applied (instilled) daily for fifteen days↓ Corneal opacity
↓ TNF-α and IL1β
↑ IL-10		[85]
The stems and leaves were blended with distilled H2O100 mg of lyophilized powder in 1 mL of DMSOIn vitro/human pterygium fibroblast primary culture-↓ Proliferation
↓ VEGF and CTGF expression at 250 μg/mL		[86]
E. hirtaEthanolic extract of aerial parts-In vivo/naphthalene-induced cataract in ratsOrally for 28 days↓ Opacity index at 200 and 400 mg/kg[98]
R. communisCastor oilCastor oil emulsionsSix clinical trials 1/meibomian gland dysfunction; dry eye; contact lens discomfort; blepharitisTopically applied (instilled) eye dropsBeneficial effects on the lipid layer, tear film integrity, eyelash health, and meibomian gland functionality[99]
O. basilicumAqueous extract from seedsExtract in 0.25% Hydroxypropyl methylcelluloseIn vivo/water-loading and steroid-induced ocular hypertension in rabbit eyesTopically applied (instilled) eye drops, single drop of extractIOP reduction at 0.5% of extract[100]
Methanolic leaves extract200 μg/mL DMEMIn vitro/selenite-induced cataractogenesis in rat lenses-Prevented selenite-induced cataract formation.
↑ GSH level
↓ MDA		[101]
Methanolic leaves Extract200 μg/mL DMEMIn vitro/selenite-induced cataractogenesis in rat lenses-Prevented alterations of the insoluble-to-soluble-protein ratio and the protein carbonyl and sulfhydryl levels.
Prevented the reduction in mRNA transcript levels of the αA- crystallin and βB1-crystallin genes		[102]
C. aurantiumHydromethanol peel extract-In vivo/naphthalene-induced cataractogenesis in ratsOrally for 28 days↓ Opacity index at 200 and 400 mg/kg
↓ Carbonyl and ↑ sulfhydryl levels
↓ MDA and LH
Restored enzymatic and non-enzymatic antioxidant enzymes		[103]
1 For detailed information, consult the review by Sandford et al. [92]. Reduction (↓); increment (↑); intraocular pressure (IOP); nitric oxide (NO); interleukin-1beta (IL-1β); interleukin- 6 (IL-6); tumor necrosis factor (TNF)-alpha (TNF-α); interleukin-10 (IL-10); reactive oxygen species (ROS), malondialdehyde (MDA); nuclear factor E2-related factor 2 (Nrf2); superoxide dismutase-2 (SOD2); cyclooxygenase-2 (COX-2); vascular endothelial growth factor (VEGF); connective tissue growth factor (CTGF); glutathione (GSH); lipid hydroperoxides (LH).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Salazar-Gómez, A.; Velo-Silvestre, A.A.; Alonso-Castro, A.J.; Hernández-Zimbrón, L.F. Medicinal Plants Used for Eye Conditions in Mexico—A Review. Pharmaceuticals 2023, 16, 1432. https://doi.org/10.3390/ph16101432

AMA Style

Salazar-Gómez A, Velo-Silvestre AA, Alonso-Castro AJ, Hernández-Zimbrón LF. Medicinal Plants Used for Eye Conditions in Mexico—A Review. Pharmaceuticals. 2023; 16(10):1432. https://doi.org/10.3390/ph16101432

Chicago/Turabian Style

Salazar-Gómez, Anuar, Amabile A. Velo-Silvestre, Angel Josabad Alonso-Castro, and Luis Fernando Hernández-Zimbrón. 2023. "Medicinal Plants Used for Eye Conditions in Mexico—A Review" Pharmaceuticals 16, no. 10: 1432. https://doi.org/10.3390/ph16101432

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop